Chemically-Induced Disorders: News and Research on Drug Hypersensitivity

MeSH tree: C25.100.468

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Antiseizure medications can produce life-threatening reactions

Molecular tests and other screening tools can lessen the risk of potentially fatal reactions to antiseizure medications that millions of Americans take for epilepsy and other conditions, but skin rashes still require speedy ...

page 2 from 2